Craniopharyngioma MRI

Jump to navigation Jump to search

Craniopharyngioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Craniopharyngioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Craniopharyngioma MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Craniopharyngioma MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Craniopharyngioma MRI

CDC on Craniopharyngioma MRI

Craniopharyngioma MRI in the news

Blogs on Craniopharyngioma MRI

Directions to Hospitals Treating Craniopharyngioma

Risk calculators and risk factors for Craniopharyngioma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

MRI

Adamantinomatous

The findings on the MRI are cysts: variable but ~80% are mostly or partly T2 hyperintense T1: iso- to hyperintense to brain (due to high protein content machinery oil cysts)

solid component T1 C+ (Gd): vivid enhancement T2: variable or mixed

calcification difficult to appreciate on conventional imaging susceptible sequences may better demonstrate calcification

MR angiography: may demonstrate displacement of the A1 segment of theanterior cerebral artery (ACA) MR spectroscopy: cyst contents may show a broad lipid spectrum, with an otherwise flat baseline 6 (Images courtesy of RadsWiki)

References


Template:WikiDoc Sources